Product Images Arformoterol Tartrate Inhalation Solution
View Photos of Packaging, Labels & Appearance
- rdp-arf-30ct-singles - RDP Arf 30ct singles carton
- rdp-arf-60ct-singles - RDP Arf 60ct singles carton
- figure-01 - figure 01
- figure-02 - figure 02
- figure-03 - figure 03
- figure-04 - figure 04
- figure-05 - figure 05
- figure-06 - figure 06
- figure-07 - figure 07
- figure 08 - figure 08
- figure-09 - figure 09
- rdp-01 - rdp 01
- rdp-02 - rdp 02
Product Label Images
The following 13 images provide visual information about the product associated with Arformoterol Tartrate Inhalation Solution NDC 76204-026 by Ritedose Pharmaceuticals, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
rdp-arf-30ct-singles - RDP Arf 30ct singles carton
This text appears to be a description of a medication called Arformoterol Tartrate Inhalation Solution. The medication is available in 2 mL vials, and each vial contains 15 mcg or meg of the active ingredient, arformoterol. The solution is intended for oral inhalation only. It is recommended to keep the medication refrigerated or at room temperature for up to 6 weeks. The text also includes contact information for customer service.*
rdp-arf-60ct-singles - RDP Arf 60ct singles carton
figure-01 - figure 01
figure-02 - figure 02
figure-03 - figure 03
figure-04 - figure 04
figure-05 - figure 05
figure-06 - figure 06
figure-07 - figure 07
figure 08 - figure 08
figure-09 - figure 09
rdp-01 - rdp 01
rdp-02 - rdp 02
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
